Ascend Wellness Holdings, Inc. cultivates, manufactures, and distributes cannabis consumer packaged goods in the U.S. Key strengths include a solid gross margin of 36.1% and a decent EBITDA margin of 20.9%, indicating operational efficiency. However, concerns arise from a negative net margin of -7.8% and a return on assets (ROA) of -1.1%, suggesting profitability challenges. The current ratio of 1.66 indicates good liquidity, but a quick ratio below 1 raises potential short-term liquidity concerns. Overall, while the company shows operational promise, its profitability metrics warrant caution.
Loading financial metrics...
Company posted a loss of $-113.8M over the last year, representing 23.3% of revenue.
Debt of $592.2M is 8.8x the company's cash position of $67.0M.
Revenue decreased 8.4% year-over-year from $533.0M to $488.3M.
Gross margin improvement of 4.5pp suggests operational efficiency gains.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2026-Q2 (June 30, 2026)